HIF3A and lung cancer: The unbiased discovery of the AHR pathway as well as pathways involved in hypoxia (HIF3A) and mucosa-mediated clearance of lung airways (FOXJ1), demonstrates the ability of SEPIRA to identify early and potentially causal pathways in lung cancer development.